Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease.

UNLABELLED Atrial natriuretic peptide (ANP) exerts a dilatory effect on coronary arteries in humans. We investigated the effects of ANP on pacing-induced myocardial ischemia during enflurane anesthesia in patients with coronary artery disease (CAD). In 20 patients with CAD, myocardial ischemia was induced by atrial pacing before and after an i.v. infusion of ANP (50 mg x kg(-1) min(-1), n = 10) or placebo (n = 10). We studied the effects of ANP or placebo on pacing-induced changes in central hemodynamics, myocardial blood flow and regional myocardial indices of lactate uptake (RMLU), and oxygen consumption (RMVO2) and extraction (RMO2E). ST-segment depression was less pronounced during pacing with ANP compared with control pacing (-0.09 +/- 0.01 vs -0.24 +/- 0.02 mV; P < 0.001). RMLU decreased to -11.1 micromol/min during control pacing compared with -0.7 micromol/min during pacing with ANP (P < 0.01). ANP did not affect pacing-induced changes in RMVO2, RMO2E, or the rate pressure product. Placebo did not affect pacing-induced changes in ST-segment depression or RMLU. In conclusion, ANP attenuates ischemic ST-segment depression and lactate release during pacing-induced myocardial ischemia in patients with CAD. The antiischemic effect of ANP was not accompanied by any improvement in the regional myocardial oxygen supply/demand relationship. IMPLICATIONS We evaluated the effects of i.v. atrial natriuretic peptide (50 ng x kg(-1) x min(-1)) on pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease. In contrast to placebo, atrial natriuretic peptide attenuated ST-segment depression and myocardial lactate production and improved left ventricular function during pacing-induced ischemia.

[1]  T. Hedner,et al.  Myocardial Circulatory and Metabolic Effects of Atrial Natriuretic Peptide After Coronary Artery Bypass Grafting , 1996, Anesthesia and analgesia.

[2]  K. Nakao,et al.  Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. , 1995, European journal of endocrinology.

[3]  M. Yokota,et al.  Improvement in exercise-induced left ventricular dysfunction by infusion of alpha-human atrial natriuretic peptide in coronary artery disease. , 1995, The American journal of cardiology.

[4]  T. Hedner,et al.  Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. , 1994, Journal of cardiothoracic and vascular anesthesia.

[5]  A. Takeshita,et al.  Beneficial Effects of Atrial Natriuretic Peptide on Exercise‐Induced Myocardial Ischemia in Patients With Stable Effort Angina Pectoris , 1993, Circulation.

[6]  A. Takeshita,et al.  Effects of synthetic human atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries. , 1991, Japanese circulation journal.

[7]  H. Herrmann,et al.  Coronary hemodynamic effects of atrial natriuretic peptide in humans. , 1990, Journal of the American College of Cardiology.

[8]  H. Herrmann,et al.  Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man. , 1990, American heart journal.

[9]  F. Cobb,et al.  Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. , 1989, Circulation.

[10]  F. Cobb,et al.  Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow‐Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature , 1989, Circulation research.

[11]  I. Palacios,et al.  Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure. , 1988, American heart journal.

[12]  R. Zimmerman,et al.  Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. , 1988, Circulation research.

[13]  K. Goetz.  Physiology and pathophysiology of atrial peptides. , 1988, The American journal of physiology.

[14]  F. Murad,et al.  Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitro. , 1986, European journal of pharmacology.

[15]  J. Laragh,et al.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. , 1985, The New England journal of medicine.

[16]  R. Raddino,et al.  Reproducibility of metabolical parameters during successive coronary sinus pacing in patients known to have coronary artery disease. , 1985, International journal of cardiology.

[17]  T. Nielsen,et al.  Reproducibility of coronary haemodynamics and cardiac metabolism during pacing-induced angina pectoris. , 1985, Clinical physiology.

[18]  S. Simonsen,et al.  Reproducibility of ischaemic lactate metabolism during atrial pacing in man. , 1983, Cardiology.

[19]  W. Nichols,et al.  In Vivo Validation of a Thermodilution Method to Determine Regional Left Ventricular Blood Flow in Patients with Coronary Disease , 1978, Circulation.

[20]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.